跳至主要内容
临床试验/NCT02818478
NCT02818478已完成不适用

Patient Reported Outcome Measures Reported Into the Danish Arthritis Registry (DANBIO) Via Computer or Tablet at Home Versus Touch Screen at the Outpatient Clinic Among Patients With Axial Spondyloarthritis or Rheumatoid Arthritis

Henrik Gudbergsen0 个研究点目标入组 42 人开始时间: 2016年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42
主要终点
HAQ

研究概览

简要总结

To investigate if electronic reporting of patient reported outcome measures from home is comparable to the traditional touch-screen solution to hospital among patients with rheumatoid arthritis and axial spondyloarthritis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Rheumatoid arthirtis OR axial spondyloarthritis
  • Active treatment and monitoring of the Knowledge Center for Rheumatology and Spine diseases, Rigshospitalet, Denmark
  • Patients must have reported patient reported outcome measures via DANBIOs touch-screen solution ≥ 3 times

排除标准

  • Impaired vision
  • Non-Danish speaking
  • No electronic device at home,, tablet or computer

结局指标

主要结局

HAQ

时间窗: 48 hours

The Health Assessment Questionnaire (HAQ) developed to retrieve quantitative information on outcomes among patients with rheumatoid arthritis

次要结局

  • 100 mm VAS global(48 hours)
  • 100 mm VAS pain(48 hours)
  • 100 mm VAS fatigue(48 hours)
  • BASDAI(48 hours)
  • BASFI(48 hours)
  • BASDAI 5 & 6(48 hours)

研究者

发起方
Henrik Gudbergsen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Henrik Gudbergsen

EU Project Coordinator

Parker Research Institute

相似试验